Add To My Watchlist

Overall Rating: 55 Neutral

Action to take: WATCH
Neutral stocks are expected to perform in line with the market over the next 12 months.
Priced Based
Fundamental Based
Positive Factors (Top 20%)
Volatility: Low-volatility stocks tends to outperform high-volatility stocks.
Growth: High-growth stocks tend to outperform low-growth stocks.
Negative Factors (Bottom 20%)
Size: Stocks of the largest companies tend to lag the returns of otherwise equally-rated smaller companies.
Value: Stocks with the highest valuations tend to produce weak or negative forward returns.
Collapse Detail

Latest Insights on CCI

dna storage stock Moderna MRNA A 1,700% Shot in the Arm: MRNA Put the Spotlight on Genomics
by Charles Sizemore May 26, 2022 Investing
Mega trends are imperative while in a bear market. Moderna helped genomics shoot to the top, see how this can help spot future trends.
Energy Transfer stock big pipeline energy stock Chevron CVX OXY stock Warren Buffett Buffett’s Bullish on Energy Too — Time to Buy Berkshire’s Top Holdings?
by Charles Sizemore May 5, 2022 Investing
Warren Buffett made big moves in the Berkshire Hathaway portfolio. Time to buy top energy stocks like Occidental Petroleum (NYSE: OXY)?
Warren Buffett Berkshire Warren Buffett Didn’t Mince Market Words — My Biggest Takeaways
by Charles Sizemore May 3, 2022 Investing
Berkshire Hathaway wrapped up its annual meeting with some advice from Warren Buffett. As market volatility increases, sanity is the solution.
3 scientists in lab High-Quality Pharma Stock Captures Powerful Biotech Mega Trend Among the most lucrative mega trends of the next decade, biotech is poised to grow revenues 77% by 2026. This Power Stock has been on the front lines of the battle against COVID-19 and rates a 96 on our proprietary system.
stock market volatility first five days Closing Bell invest with ABUSE trend rules Johnson & Johnson stock JNJ Johnson & Johnson Stock Is STILL the Cure for a Volatile Market
by Charles Sizemore April 13, 2022 Investing
Market volatility is back on the menu, and Johnson & Johnson stock (NYSE: JNJ) is still a perfect dividend growth play in this environment.